Danimer Scientific, Inc.
DNMR · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $4,162 | $7,238 | $31,721 | $79,497 |
| - Cash | $59 | $63 | $286 | $378 |
| + Debt | $408 | $314 | $287 | $84 |
| Enterprise Value | $4,511 | $7,489 | $31,722 | $79,203 |
| Revenue | $47 | $53 | $59 | $47 |
| % Growth | -12.3% | -9.4% | 24.1% | – |
| Gross Profit | -$27 | -$8 | $1 | $11 |
| % Margin | -57.7% | -14.9% | 1.5% | 24.2% |
| EBITDA | -$96 | -$103 | -$88 | -$2 |
| % Margin | -205.9% | -194.5% | -149.3% | -3.8% |
| Net Income | -$155 | -$180 | -$60 | -$9 |
| % Margin | -333% | -337.8% | -102.3% | -18.7% |
| EPS Diluted | -1.52 | -1.78 | -0.65 | -0.1 |
| % Growth | 14.6% | -173.8% | -550% | – |
| Operating Cash Flow | -$47 | -$62 | -$63 | -$14 |
| Capital Expenditures | -$28 | -$164 | -$185 | -$38 |
| Free Cash Flow | -$75 | -$226 | -$248 | -$52 |